Edition:
United Kingdom

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

76.52EUR
21 Sep 2018
Change (% chg)

€0.70 (+0.92%)
Prev Close
€75.82
Open
€76.77
Day's High
€76.99
Day's Low
€75.73
Volume
8,610,344
Avg. Vol
3,753,560
52-wk High
€118.04
52-wk Low
€69.40

Chart for

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and... (more)

Overall

Beta: 0.98
Market Cap(Mil.): €96,918.28
Shares Outstanding(Mil.): 826.95
Dividend: 2.70
Yield (%): 2.30

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 22.18 30.93 32.76
EPS (TTM): 5.29 -- --
ROI: 8.69 15.07 14.61
ROE: 16.39 16.59 16.33

UPDATE 3-Bundesliga Results

Sep 22 (OPTA) - Results and fixtures for the Bundesliga on Saturday (start times are CET) Hoffenheim (1) 1 Borussia Dortmund (0) 1 Hertha BSC (2) 4 Borussia M'gladbach (1) 2 Augsburg (1) 2 Werder Bremen (2) 3 Wolfsburg (0) 1 Freiburg (2) 3 Nürnberg (0) 2 Hannover 96 (0) 0 Schalke 04 v Bayern München (18:30) Sunday, September 23 fixtures (CET/GMT) Bayer Leverkusen v Mainz 05 (1530/1330) Eintra

4:25pm BST

Doctors win battle with drug giants over cheaper eye medicine

ZURICH Drug giants Novartis , Bayer and Roche on Friday lost a bid to stop British doctors from recommending a cheaper drug option for people with an eye disease that causes blindness, the High Court in London ruled.

21 Sep 2018

Bayer hemophilia treatment wins thumbs-up from EU panel

Sept 21 Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.

21 Sep 2018

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

19 Sep 2018

Factbox: Bayer's Monsanto faces broad U.S. glyphosate litigation

Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the company's glyphosate-based weed-killers, including the widely-used Roundup brand, caused his cancer.

19 Sep 2018

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

19 Sep 2018

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Sept 18 Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

19 Sep 2018

Bayer says agriculture trade flows may change amid tariffs dispute

MONHEIM, Germany, Sept 18 Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities.

18 Sep 2018

Bayer puts stake in chemical park operator up for sale - sources

FRANKFURT Bayer is inviting financial investors to bid for its 60 percent stake in chemical park operator Currenta after initially failing to agree a sale to its former chemicals subsidiary Covestro , three people familiar with the matter told Reuters.

17 Sep 2018

Exclusive: Bayer puts stake in chemical park operator up for sale - sources

FRANKFURT Bayer is inviting financial investors to bid for its 60 percent stake in chemical park operator Currenta after initially failing to agree a sale to its former chemicals subsidiary Covestro, three people familiar with the matter told Reuters.

17 Sep 2018

Earnings vs. Estimates